Premium
Arcellx Inc (ACLX)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.
-- Recently released ASH abstracts for the company’s Phase 1 and iMMagine-1 studies investigating anito-cel in relapsed or refractory multiple myeloma patients continue to demonstrate durability...
-- 30.2-month median progression-free survival with a median follow-up of 38.1 months in the Phase 1 study of anito-cel; median overall survival not reached -- -- Preliminary results from 58...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -17.835 | -16.8501110114 | 105.845 | 107.3699 | 86.39 | 573127 | 93.96511692 | CS |
| 4 | -1.68 | -1.87311851934 | 89.69 | 107.3699 | 78.56 | 653895 | 91.61668043 | CS |
| 12 | 16.84 | 23.6616551918 | 71.17 | 107.3699 | 64.1 | 544577 | 85.37694861 | CS |
| 26 | 34.28 | 63.800483901 | 53.73 | 107.3699 | 49 | 497230 | 71.58678228 | CS |
| 52 | 32.75 | 59.26529135 | 55.26 | 107.3699 | 46.42 | 511964 | 64.61101385 | CS |
| 156 | 69.01 | 363.210526316 | 19 | 107.3699 | 6.035 | 483841 | 42.80694615 | CS |
| 260 | 69.01 | 363.210526316 | 19 | 107.3699 | 6.035 | 483841 | 42.80694615 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
